As part of this year’s International Coeliac Day, AOECS is raising awareness for an improvement in diagnosis rates of coeliac disease.

As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the…

A year after I graduated, I was working in an emergency department when one of my colleagues killed someone.

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

The importance of dairy products, including yogurt, to bone health has been recognised again today with the announcement of a new collaboration between…

Norgine B.V. (“Norgine”) and Innovacell today announced that the first patient has been dosed in the Phase IIb STEFFI study, which has been designed to…

People with advanced cancer and other serious illnesses like dementia could soon benefit from early access to innovative and promising treatments.

NICE, the health and social care guidance body, is currently appraising canagliflozin (Invokana, Janssen-Cilag) when used in combination with…

This educational seminar, supported by an independent educational grant from Daiichi Sankyo, was held at the AHA congress in Dallas on 19th November 2013.

The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results.